FDA Inspection 1202722 — New York Reproductive Wellness Medicine, P.C.

New York Reproductive Wellness Medicine, P.C. — FEI 3010122933

The FDA completed an inspection of New York Reproductive Wellness Medicine, P.C. on April 7, 2023 in Syosset, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 7, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Syosset, NY (United States)

Citations

IDCFRDescription
1222921 CFR 1271.50(a)Determination based on screening and testing
1224221 CFR 1271.55(c)Name and personal info on accompanying records